![Max Petersson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Max Petersson
Chief Operating Officer at Accuro Immunology AB
Max Petersson active positions
Companies | Position | Start | End |
---|---|---|---|
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Chief Operating Officer | - | - |
Career history of Max Petersson
Former positions of Max Petersson
Companies | Position | Start | End |
---|---|---|---|
AngioGenetics AB
![]() AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Corporate Officer/Principal | - | - |
Training of Max Petersson
Karolinska Institutet | Doctorate Degree |
Statistics
International
Sweden | 4 |
Operational
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
AngioGenetics AB
![]() AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Health Technology |
- Stock Market
- Insiders
- Max Petersson
- Experience